Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Agitation in Patients With Dementia of the Alzheimer's Type”

36 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 36 results

Testing effectiveness (Phase 2)Ended earlyNCT01766336
What this trial is testing

A 36-Week Safety Extension Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
OPKO Health, Inc. 296
Not applicableStudy completedNCT01329536
What this trial is testing

The Occurrence of the ApoE4 Allele in Agitated In-Patients With Late-Onset Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseAgitation
Avera McKennan Hospital & University Health Center 50
Large-scale testing (Phase 3)Study completedNCT04947553
What this trial is testing

Assess the Long-term Safety and Efficacy of AXS-05 in Subjects With Alzheimer's Disease Agitation

Who this might be right for
Agitation in Patients With Dementia of the Alzheimer's TypeAlzheimer DiseaseAgitation, Psychomotor
Axsome Therapeutics, Inc. 456
Large-scale testing (Phase 3)Study completedNCT04797715
What this trial is testing

Assessing Clinical Outcomes in Alzheimer's Disease Agitation

Who this might be right for
Agitation in Patients With Dementia of the Alzheimer's TypeAlzheimer DiseaseAgitation,Psychomotor
Axsome Therapeutics, Inc. 178
Large-scale testing (Phase 3)Ended earlyNCT02168920
What this trial is testing

Aripiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type

Who this might be right for
Agitation Associated With Dementia of the Alzheimer's Type
Otsuka Pharmaceutical Co., Ltd. 150
Large-scale testing (Phase 3)Study completedNCT03393520
What this trial is testing

Assessment of the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Who this might be right for
Agitation in Patients With Dementia of the Alzheimer's Type
Otsuka Pharmaceutical Development & Commercialization, Inc. 601
Large-scale testing (Phase 3)Not Yet RecruitingNCT07422311
What this trial is testing

To Evaluate the Efficacy, Safety, and Tolerability of Dronabinol Oral Solution for Agitation in Patients With Alzheimer's Disease

Who this might be right for
Agitation in Dementia
Benuvia Therapeutics Inc. 140
Testing effectiveness (Phase 2)UnknownNCT04436081
What this trial is testing

Effects of THC-Free CBD Oil on Agitation in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseDementiaMajor Neurocognitive Disorder With Aggressive Behavior
Eastern Virginia Medical School 40
Testing effectiveness (Phase 2)Study completedNCT01584440
What this trial is testing

Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Participants With Alzheimer's Disease

Who this might be right for
AgitationAlzheimer's Disease
Avanir Pharmaceuticals 220
Large-scale testing (Phase 3)Ended earlyNCT02817906
What this trial is testing

ITI-007 for the Treatment of Agitation in Patients With Dementia, Including Alzheimer's Disease

Who this might be right for
Agitation in Dementia, Including Alzheimer's Disease
Intra-Cellular Therapies, Inc. 177
Large-scale testing (Phase 3)Ended earlyNCT04408755
What this trial is testing

Assessment of the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Who this might be right for
Agitation in Patients With Dementia of the Alzheimer's Type
Otsuka Pharmaceutical Development & Commercialization, Inc. 184
Large-scale testing (Phase 3)Study completedNCT05557409
What this trial is testing

Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation

Who this might be right for
Agitation in Patients With Dementia of the Alzheimer's TypeAlzheimer DiseaseAgitation
Axsome Therapeutics, Inc. 408
Large-scale testing (Phase 3)Ended earlyNCT06736509
What this trial is testing

An Open-Label Study to Assess the Long-term Safety of AXS-05 in Subjects With Dementia of the Alzheimer's Type, ADVANCE-2 and ACCORD-2 Extension Study

Who this might be right for
Agitation in Patients With Dementia of the Alzheimer's TypeAlzheimer DiseaseAgitation, Psychomotor
Axsome Therapeutics, Inc. 139
Testing effectiveness (Phase 2)Looking for participantsNCT06651567
What this trial is testing

Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia

Who this might be right for
Agitation Associated With Alzheimer's Dementia
Intra-Cellular Therapies, Inc. 320
Large-scale testing (Phase 3)Study completedNCT03620981
What this trial is testing

Brexpiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type

Who this might be right for
Agitation Associated With Dementia of the Alzheimer's Type
Otsuka Pharmaceutical Co., Ltd. 410
Testing effectiveness (Phase 2)Study completedNCT00843518
What this trial is testing

Treatment for Aggression and Agitation in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Eli Lilly and Company 132
Not applicableStudy completedNCT00015548
What this trial is testing

CATIE-Alzheimer's Disease Trial

Who this might be right for
Alzheimer's Disease
National Institute of Mental Health (NIMH) 450
Testing effectiveness (Phase 2)Study completedNCT01735630
What this trial is testing

Efficacy and Safety Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
OPKO Health, Inc. 350
Testing effectiveness (Phase 2)Study completedNCT02471196
What this trial is testing

Efficacy of ORM-12741 on Agitation/Aggression Symptoms in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Orion Corporation, Orion Pharma 308
Large-scale testing (Phase 3)Study completedNCT02442765
What this trial is testing

Efficacy, Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Who this might be right for
Agitation in Patients With Dementia of the Alzheimer's Type
Otsuka Pharmaceutical Development & Commercialization, Inc. 387
Load More Results